Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Targum

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Psychopharmacology|June 27, 2003
A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorderDouglas E Feltner, Jerri G Crockatt, Steven J Dubovsky, et al.
Schizophrenia Research|March 13, 2026
Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophreniaSteven D Targum, Carolyn Watson, Amy Claxton, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2021
Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's DiseaseSteven D Targum, Lisa Fosdick, Kristen E Drake, et al.
Journal of Neurosurgery|December 20, 2015
Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trialFrancisco A Ponce, Wael F Asaad, Kelly D Foote, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's DiseaseAndres M Lozano, Lisa Fosdick, M Mallar Chakravarty, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJeannie-Marie S Leoutsakos, Haijuan Yan, William S Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's diseaseJürgen Germann, Robert S C Amaral, Jennifer Tomaszczyk, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Clinical Psychopharmacology|June 27, 2003
A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorderDouglas E Feltner, Jerri G Crockatt, Steven J Dubovsky, et al.
Schizophrenia Research|March 13, 2026
Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophreniaSteven D Targum, Carolyn Watson, Amy Claxton, et al.
Journal of Alzheimer'S Disease : JAD|June 21, 2021
Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's DiseaseSteven D Targum, Lisa Fosdick, Kristen E Drake, et al.
Journal of Neurosurgery|December 20, 2015
Bilateral deep brain stimulation of the fornix for Alzheimer's disease: surgical safety in the ADvance trialFrancisco A Ponce, Wael F Asaad, Kelly D Foote, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's DiseaseAndres M Lozano, Lisa Fosdick, M Mallar Chakravarty, et al.
Journal of Alzheimer'S Disease : JAD|June 20, 2018
Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJeannie-Marie S Leoutsakos, Haijuan Yan, William S Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Biomarker changes associated with fornix deep brain stimulation in Alzheimer's diseaseJürgen Germann, Robert S C Amaral, Jennifer Tomaszczyk, et al.
Pageof 8